BIIB logo

Biogen (BIIB) Cash from financing

annual CFF:

-$683.50M-$832.80M(-557.80%)
December 31, 2024

Summary

  • As of today (June 30, 2025), BIIB annual cash flow from financing activities is -$683.50 million, with the most recent change of -$832.80 million (-557.80%) on December 31, 2024.
  • During the last 3 years, BIIB annual CFF has risen by +$1.40 billion (+67.24%).
  • BIIB annual CFF is now -187.28% below its all-time high of $783.10 million, reached on December 31, 2015.

Performance

BIIB Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

quarterly CFF:

-$23.00M-$30.90M(-391.14%)
March 31, 2025

Summary

  • As of today (June 30, 2025), BIIB quarterly cash flow from financing activities is -$23.00 million, with the most recent change of -$30.90 million (-391.14%) on March 31, 2025.
  • Over the past year, BIIB quarterly CFF has increased by +$416.60 million (+94.77%).
  • BIIB quarterly CFF is now -100.79% below its all-time high of $2.91 billion, reached on September 30, 2015.

Performance

BIIB quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

TTM CFF:

-$266.90M+$416.60M(+60.95%)
March 31, 2025

Summary

  • As of today (June 30, 2025), BIIB TTM cash flow from financing activities is -$266.90 million, with the most recent change of +$416.60 million (+60.95%) on March 31, 2025.
  • Over the past year, BIIB TTM CFF has dropped by -$20.00 million (-8.10%).
  • BIIB TTM CFF is now -110.80% below its all-time high of $2.47 billion, reached on September 30, 2015.

Performance

BIIB TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBIIBcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

BIIB Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-557.8%+94.8%-8.1%
3 y3 years+67.2%-39.4%+79.8%
5 y5 years+88.3%+99.0%+96.4%

BIIB Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-557.8%+67.2%-102.7%+98.2%-133.9%+85.0%
5 y5-year-557.8%+88.3%-102.7%+99.0%-133.9%+96.4%
alltimeall time-187.3%+88.3%-100.8%+99.2%-110.8%+96.4%

BIIB Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
-$23.00M(-391.1%)
-$266.90M(-61.0%)
Dec 2024
-$683.50M(-557.8%)
$7.90M(-219.7%)
-$683.50M(-48.9%)
Sep 2024
-
-$6.60M(-97.3%)
-$1.34B(+177.3%)
Jun 2024
-
-$245.20M(-44.2%)
-$482.30M(+95.3%)
Mar 2024
-
-$439.60M(-32.0%)
-$246.90M(-265.4%)
Dec 2023
$149.30M(-108.5%)
-$646.10M(-176.1%)
$149.30M(-81.1%)
Sep 2023
-
$848.60M(-8759.2%)
$788.00M(-160.0%)
Jun 2023
-
-$9.80M(-77.4%)
-$1.31B(-26.0%)
Mar 2023
-
-$43.40M(+486.5%)
-$1.77B(+1.5%)
Dec 2022
-$1.75B(-16.2%)
-$7.40M(-99.4%)
-$1.75B(+1.0%)
Sep 2022
-
-$1.25B(+165.5%)
-$1.73B(+41.3%)
Jun 2022
-
-$471.50M(+2757.6%)
-$1.22B(-7.1%)
Mar 2022
-
-$16.50M(-268.4%)
-$1.32B(-36.8%)
Dec 2021
-$2.09B(-60.4%)
$9.80M(-101.3%)
-$2.09B(-16.5%)
Sep 2021
-
-$746.50M(+32.2%)
-$2.50B(-18.5%)
Jun 2021
-
-$564.50M(-28.1%)
-$3.06B(-19.6%)
Mar 2021
-
-$785.00M(+95.7%)
-$3.81B(-27.7%)
Dec 2020
-$5.27B(-10.0%)
-$401.10M(-69.4%)
-$5.27B(-24.5%)
Sep 2020
-
-$1.31B(-0.0%)
-$6.99B(+9.8%)
Jun 2020
-
-$1.31B(-41.5%)
-$6.36B(-14.3%)
Mar 2020
-
-$2.25B(+6.1%)
-$7.43B(+26.7%)
Dec 2019
-$5.86B(+31.0%)
-$2.12B(+207.2%)
-$5.86B(+13.1%)
Sep 2019
-
-$689.00M(-71.0%)
-$5.18B(+16.0%)
Jun 2019
-
-$2.38B(+249.7%)
-$4.47B(-8.5%)
Mar 2019
-
-$679.30M(-52.7%)
-$4.88B(+9.2%)
Dec 2018
-$4.47B(+87.9%)
-$1.44B(-5825.1%)
-$4.47B(+19.5%)
Sep 2018
-
$25.10M(-100.9%)
-$3.74B(-1.2%)
Jun 2018
-
-$2.79B(+939.3%)
-$3.79B(+116.8%)
Mar 2018
-
-$268.60M(-62.1%)
-$1.75B(-26.6%)
Dec 2017
-$2.38B(+126.1%)
-$708.10M(+3531.3%)
-$2.38B(-0.8%)
Sep 2017
-
-$19.50M(-97.4%)
-$2.40B(-10.6%)
Jun 2017
-
-$751.00M(-16.7%)
-$2.68B(+37.7%)
Mar 2017
-
-$901.40M(+24.1%)
-$1.95B(+85.2%)
Dec 2016
-$1.05B(-234.4%)
-$726.50M(+138.0%)
-$1.05B(-58.4%)
Sep 2016
-
-$305.30M(+1832.3%)
-$2.53B(-469.0%)
Jun 2016
-
-$15.80M(+216.0%)
$685.10M(-1.7%)
Mar 2016
-
-$5.00M(-99.8%)
$697.30M(-11.0%)
Dec 2015
$783.10M(-203.6%)
-$2.20B(-175.7%)
$783.10M(-68.3%)
Sep 2015
-
$2.91B(<-9900.0%)
$2.47B(-624.5%)
Jun 2015
-
-$3.60M(-104.5%)
-$471.21M(-40.4%)
Mar 2015
-
$80.80M(-115.7%)
-$789.98M(+4.5%)
Dec 2014
-$755.90M(+5.5%)
-$513.29M(+1361.4%)
-$755.90M(+226.7%)
Sep 2014
-
-$35.12M(-89.1%)
-$231.40M(-55.1%)
Jun 2014
-
-$322.36M(-380.6%)
-$514.80M(+41.7%)
Mar 2014
-
$114.88M(+924.8%)
-$363.20M(-49.3%)
Dec 2013
-$716.50M(-18.3%)
$11.21M(-103.5%)
-$716.50M(-3.6%)
Sep 2013
-
-$318.52M(+86.5%)
-$743.23M(+64.1%)
Jun 2013
-
-$170.76M(-28.4%)
-$452.96M(-35.3%)
Mar 2013
-
-$238.42M(+1435.8%)
-$699.64M(-20.3%)
Dec 2012
-$877.48M(+174.3%)
-$15.52M(-45.0%)
-$877.48M(-12.7%)
Sep 2012
-
-$28.25M(-93.2%)
-$1.00B(-6.6%)
Jun 2012
-
-$417.44M(+0.3%)
-$1.08B(+69.0%)
Mar 2012
-
-$416.26M(+191.5%)
-$636.29M(+98.9%)
Dec 2011
-$319.86M(-82.1%)
-$142.81M(+44.1%)
-$319.86M(-754.5%)
Sep 2011
-
-$99.13M(-552.5%)
$48.87M(-115.6%)
Jun 2011
-
$21.91M(-121.9%)
-$313.26M(-77.0%)
Mar 2011
-
-$99.83M(-144.2%)
-$1.36B(-23.7%)
Dec 2010
-$1.78B(+146.5%)
$225.93M(-149.0%)
-$1.78B(-33.3%)
Sep 2010
-
-$461.26M(-55.0%)
-$2.68B(+21.2%)
Jun 2010
-
-$1.03B(+96.0%)
-$2.21B(+87.2%)
Mar 2010
-
-$523.46M(-21.5%)
-$1.18B(+63.0%)
Dec 2009
-$724.15M(-41.3%)
-$666.76M(<-9900.0%)
-$724.15M(+86.1%)
Sep 2009
-
$6.38M(+102.6%)
-$389.19M(+49.3%)
Jun 2009
-
$3.15M(-104.7%)
-$260.74M(-49.3%)
Mar 2009
-
-$66.93M(-79.8%)
-$514.02M(-58.4%)
Dec 2008
-$1.23B(+67.9%)
-$331.79M(-346.1%)
-$1.23B(+201.7%)
Sep 2008
-
$134.83M(-153.9%)
-$409.18M(-78.0%)
Jun 2008
-
-$250.13M(-68.2%)
-$1.86B(+20.3%)
Mar 2008
-
-$787.53M(-259.5%)
-$1.55B(+110.4%)
Dec 2007
-$735.22M
$493.65M(-137.5%)
-$735.22M(-36.6%)
Sep 2007
-
-$1.32B(-2145.7%)
-$1.16B(+654.0%)
DateAnnualQuarterlyTTM
Jun 2007
-
$64.41M(+164.0%)
-$153.89M(-25.9%)
Mar 2007
-
$24.40M(-64.4%)
-$207.66M(+39.9%)
Dec 2006
-$148.41M(-84.4%)
$68.57M(-122.0%)
-$148.41M(-0.5%)
Sep 2006
-
-$311.27M(-3027.1%)
-$149.10M(-182.2%)
Jun 2006
-
$10.63M(-87.3%)
$181.46M(-125.1%)
Mar 2006
-
$83.66M(+23.2%)
-$723.69M(-23.7%)
Dec 2005
-$948.52M(+110.3%)
$67.88M(+251.9%)
-$948.52M(-1.9%)
Sep 2005
-
$19.29M(-102.2%)
-$967.10M(-25.5%)
Jun 2005
-
-$894.52M(+533.6%)
-$1.30B(+87.9%)
Mar 2005
-
-$141.18M(-386.3%)
-$690.45M(+53.1%)
Dec 2004
-$450.96M(-981.0%)
$49.31M(-115.9%)
-$450.96M(-2.2%)
Sep 2004
-
-$310.92M(+8.1%)
-$461.00M(+212.9%)
Jun 2004
-
-$287.65M(-392.6%)
-$147.34M(-201.5%)
Mar 2004
-
$98.31M(+150.4%)
$145.22M(+183.7%)
Dec 2003
$51.19M(-91.2%)
$39.26M(+1334.6%)
$51.19M(-91.3%)
Sep 2003
-
$2.74M(-44.2%)
$585.67M(+0.0%)
Jun 2003
-
$4.91M(+14.7%)
$585.58M(-0.2%)
Mar 2003
-
$4.28M(-99.3%)
$586.99M(+0.5%)
Dec 2002
$584.06M(-1104.3%)
$573.75M(>+9900.0%)
$584.06M(-9360.6%)
Sep 2002
-
$2.65M(-58.0%)
-$6.31M(-85.6%)
Jun 2002
-
$6.31M(+368.1%)
-$43.80M(-28.6%)
Mar 2002
-
$1.35M(-108.1%)
-$61.33M(+5.5%)
Dec 2001
-$58.16M(-78.4%)
-$16.62M(-52.3%)
-$58.16M(-58.1%)
Sep 2001
-
-$34.84M(+210.5%)
-$138.89M(+15.5%)
Jun 2001
-
-$11.22M(-347.9%)
-$120.27M(-40.6%)
Mar 2001
-
$4.53M(-104.6%)
-$202.44M(-24.8%)
Dec 2000
-$269.14M(+120.6%)
-$97.36M(+500.3%)
-$269.14M(-20.4%)
Sep 2000
-
-$16.22M(-82.6%)
-$338.11M(+8.3%)
Jun 2000
-
-$93.39M(+50.2%)
-$312.19M(+18.7%)
Mar 2000
-
-$62.17M(-62.6%)
-$262.90M(+115.4%)
Dec 1999
-$122.03M(+125.7%)
-$166.33M(-1814.7%)
-$122.03M(-625.5%)
Sep 1999
-
$9.70M(-122.0%)
$23.22M(+182.4%)
Jun 1999
-
-$44.10M(-156.0%)
$8.22M(-77.9%)
Mar 1999
-
$78.70M(-473.4%)
$37.22M(-168.8%)
Dec 1998
-$54.08M(-182.1%)
-$21.08M(+297.7%)
-$54.08M(-721.8%)
Sep 1998
-
-$5.30M(-64.9%)
$8.70M(-37.9%)
Jun 1998
-
-$15.10M(+19.8%)
$14.00M(+41.4%)
Mar 1998
-
-$12.60M(-130.2%)
$9.90M(-85.0%)
Dec 1997
$65.90M(+27.3%)
$41.70M(>+9900.0%)
$65.90M(+64.4%)
Sep 1997
-
$0.00(-100.0%)
$40.07M(-21.8%)
Jun 1997
-
-$19.20M(-144.2%)
$51.27M(-38.7%)
Mar 1997
-
$43.40M(+173.4%)
$83.67M(+61.6%)
Dec 1996
$51.77M(-30.0%)
$15.87M(+41.7%)
$51.77M(-16.0%)
Sep 1996
-
$11.20M(-15.2%)
$61.65M(-13.0%)
Jun 1996
-
$13.20M(+14.8%)
$70.85M(+18.6%)
Mar 1996
-
$11.50M(-55.3%)
$59.75M(-19.2%)
Dec 1995
$73.95M(+375.7%)
$25.75M(+26.2%)
$73.95M(+50.8%)
Sep 1995
-
$20.40M(+871.4%)
$49.05M(+46.6%)
Jun 1995
-
$2.10M(-91.8%)
$33.45M(-14.3%)
Mar 1995
-
$25.70M(+2941.4%)
$39.05M(+151.2%)
Dec 1994
$15.54M(+99.3%)
$845.00K(-82.4%)
$15.54M(-15.5%)
Sep 1994
-
$4.80M(-37.7%)
$18.40M(+21.9%)
Jun 1994
-
$7.70M(+250.0%)
$15.10M(+69.7%)
Mar 1994
-
$2.20M(-40.5%)
$8.90M(+14.1%)
Dec 1993
$7.80M(-22.0%)
$3.70M(+146.7%)
$7.80M(-28.4%)
Sep 1993
-
$1.50M(0.0%)
$10.90M(-5.2%)
Jun 1993
-
$1.50M(+36.4%)
$11.50M(+8.5%)
Mar 1993
-
$1.10M(-83.8%)
$10.60M(+6.0%)
Dec 1992
$10.00M(-88.4%)
$6.80M(+223.8%)
$10.00M(-88.7%)
Sep 1992
-
$2.10M(+250.0%)
$88.30M(-0.5%)
Jun 1992
-
$600.00K(+20.0%)
$88.70M(+1.1%)
Mar 1992
-
$500.00K(-99.4%)
$87.70M(+1.4%)
Dec 1991
$86.50M(-4905.6%)
$85.10M(+3304.0%)
$86.50M(>+9900.0%)
Sep 1991
-
$2.50M(-725.0%)
$100.00K(-105.3%)
Jun 1991
-
-$400.00K(-42.9%)
-$1.90M(+18.8%)
Mar 1991
-
-$700.00K(-46.2%)
-$1.60M(-11.1%)
Dec 1990
-$1.80M(-102.8%)
-$1.30M(-360.0%)
-$1.80M(+260.0%)
Sep 1990
-
$500.00K(-600.0%)
-$500.00K(-50.0%)
Jun 1990
-
-$100.00K(-88.9%)
-$1.00M(+11.1%)
Mar 1990
-
-$900.00K
-$900.00K
Dec 1989
$64.50M
-
-

FAQ

  • What is Biogen annual cash flow from financing activities?
  • What is the all time high annual CFF for Biogen?
  • What is Biogen annual CFF year-on-year change?
  • What is Biogen quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Biogen?
  • What is Biogen quarterly CFF year-on-year change?
  • What is Biogen TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Biogen?
  • What is Biogen TTM CFF year-on-year change?

What is Biogen annual cash flow from financing activities?

The current annual CFF of BIIB is -$683.50M

What is the all time high annual CFF for Biogen?

Biogen all-time high annual cash flow from financing activities is $783.10M

What is Biogen annual CFF year-on-year change?

Over the past year, BIIB annual cash flow from financing activities has changed by -$832.80M (-557.80%)

What is Biogen quarterly cash flow from financing activities?

The current quarterly CFF of BIIB is -$23.00M

What is the all time high quarterly CFF for Biogen?

Biogen all-time high quarterly cash flow from financing activities is $2.91B

What is Biogen quarterly CFF year-on-year change?

Over the past year, BIIB quarterly cash flow from financing activities has changed by +$416.60M (+94.77%)

What is Biogen TTM cash flow from financing activities?

The current TTM CFF of BIIB is -$266.90M

What is the all time high TTM CFF for Biogen?

Biogen all-time high TTM cash flow from financing activities is $2.47B

What is Biogen TTM CFF year-on-year change?

Over the past year, BIIB TTM cash flow from financing activities has changed by -$20.00M (-8.10%)
On this page